• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081751)   Today's Articles (101)
For: Schmidt D, Kollan C, Bartmeyer B, Bremer V, Schikowski T, Friebe M, Schellberg S, Scholten S, Bickel M, Hanhoff N, Rüsenberg R, Schewe K; NEPOS study group. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany. Infection 2022. [PMID: 36168098 DOI: 10.1007/s15010-022-01919-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Accepted: 08/29/2022] [Indexed: 11/20/2022]
Number Cited by Other Article(s)
1
Menozzi M, Trapani MDD, Burastero GJ, Volpi S, Cuomo G, Mazzitelli M, Barbaro F, Labate L, Cattelan AM, Di Biagio A, Mussini C. Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity. AIDS Behav 2025:10.1007/s10461-025-04736-5. [PMID: 40402466 DOI: 10.1007/s10461-025-04736-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/16/2025] [Indexed: 05/23/2025]
2
Wijstma E, Jongen VW, Boyd A, de Vries HJC, Schim van der Loeff MF, Prins M, Hoornenborg E. Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized preexposure prophylaxis care in Amsterdam, the Netherlands. AIDS 2025;39:75-84. [PMID: 39352137 DOI: 10.1097/qad.0000000000004027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Accepted: 09/24/2024] [Indexed: 12/07/2024]
3
Kounta CH, Chazelle E, Ousseine YM, Lot F, Velter A. Factors associated with bacterial sexually transmitted infection screening uptake and diagnosis among men who have sex with men in France. BMC Infect Dis 2024;24:1431. [PMID: 39695405 DOI: 10.1186/s12879-024-10310-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 12/04/2024] [Indexed: 12/20/2024]  Open
4
Ayerdi O, Orviz E, Valls Carbó A, Fernández Piñeiro N, Vera García M, Puerta López T, Ballesteros Martín J, Rodríguez Martín C, Baza Caraciolo B, Lejarraga Cañas C, Pérez-García JA, Carrió D, García Lotero M, Ferreras Forcada M, González Polo M, Raposo Utrilla M, Delgado-Iribarren A, Del Romero-Guerrero J, Estrada Pérez V. Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (ENGLISH ED.) 2024;42:570-576. [PMID: 38492988 DOI: 10.1016/j.eimce.2024.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 01/02/2024] [Indexed: 03/18/2024]
5
Pedrosa NL, Pinheiro PM, Filho FWBH, de Araujo WN. Incidence and risk factors associated with acquired syphilis in HIV pre-exposure prophylaxis users. PLoS One 2024;19:e0303320. [PMID: 38968238 PMCID: PMC11226132 DOI: 10.1371/journal.pone.0303320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Accepted: 06/08/2024] [Indexed: 07/07/2024]  Open
6
Schmidt D, Duport Y, Kollan C, Marcus U, Iannuzzi S, von Kleist M. Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany. BMC Public Health 2024;24:1691. [PMID: 38918748 PMCID: PMC11197325 DOI: 10.1186/s12889-024-19198-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Accepted: 06/19/2024] [Indexed: 06/27/2024]  Open
7
Salmanton-García J, Simon M, Groll AH, Kurzai O, Lahmer T, Lehrnbecher T, Schroeder M, Cornely OA, Stemler J. Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany. JAC Antimicrob Resist 2024;6:dlae083. [PMID: 38812581 PMCID: PMC11135635 DOI: 10.1093/jacamr/dlae083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2024] [Accepted: 05/12/2024] [Indexed: 05/31/2024]  Open
8
Krings A, Schmidt D, Kollan C, Meixenberger K, Bannert N, Münstermann D, Tiemann C, Bremer V, Gunsenheimer-Bartmeyer B. Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men. HIV Med 2024;25:201-211. [PMID: 37786263 DOI: 10.1111/hiv.13554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 09/12/2023] [Indexed: 10/04/2023]
9
Prins H, Dörre A, Schmidt D. Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic. Front Pharmacol 2023;14:1241310. [PMID: 38026934 PMCID: PMC10654745 DOI: 10.3389/fphar.2023.1241310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Accepted: 10/16/2023] [Indexed: 12/01/2023]  Open
10
Schmidt D, Kollan C, Schewe K, Hanhoff N, Rüsenberg R, Friebe M, Schikowski T, Schink SB, Marcus U, Koppe U, Jansen K, Streeck H, Ottensmeyer P, An der Heiden M, Bannert N, M'Bayo R, Ceres M, Weber L, Sweers H, Schmidt AJ, Tietz H, Danan E, Bendig J, Kloep S, Neumann A, Valbert F, Wasem J, Bartmeyer B, Bremer V. [Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2023;66:1008-1018. [PMID: 37436444 PMCID: PMC10465680 DOI: 10.1007/s00103-023-03733-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 05/20/2023] [Indexed: 07/13/2023]
11
Haberer JE, Mujugira A, Mayer KH. The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities. Lancet HIV 2023:S2352-3018(23)00079-6. [PMID: 37178710 DOI: 10.1016/s2352-3018(23)00079-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 03/19/2023] [Accepted: 03/27/2023] [Indexed: 05/15/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA